amitriptyline has been researched along with Dejerine-Roussy Syndrome in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kluger, NJ | 1 |
| Clifford, JS | 1 |
| Cavanagh, RJ | 1 |
| Griffith, WL | 1 |
| Koppel, BS | 1 |
2 other studies available for amitriptyline and Dejerine-Roussy Syndrome
| Article | Year |
|---|---|
A case of a chemically dependent patient with a thalamic pain syndrome treated with amitriptyline.
Topics: Alcoholism; Amitriptyline; Cerebral Infarction; Flurazepam; Follow-Up Studies; Humans; Male; Middle | 1991 |
Amitriptyline in the treatment of thalamic pain.
Topics: Adult; Aged; Amitriptyline; Female; Humans; Male; Pain, Intractable; Thalamic Diseases | 1986 |